Investigator-Initiated Clinical Trials to assess the safety of SK-818 in patients with operable breast cancer
Latest Information Update: 30 Mar 2020
At a glance
- Drugs Propagermanium (Primary)
- Indications Carcinoma; Early breast cancer
- Focus Adverse reactions
- 01 Mar 2020 Results published in the Cancer Science
- 15 Mar 2018 Status changed from active, no longer recruiting to completed.
- 09 Nov 2017 Status changed from recruiting to active, no longer recruiting.